Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2023-04 Issue:4 Volume:24 Page:392-402
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Monk Bradley J,Tewari Krishnansu S,Dubot Coraline,Caceres M Valeria,Hasegawa Kosei,Shapira-Frommer Ronnie,Salman Pamela,Yañez Eduardo,Gümüş Mahmut,Hurtado de Mendoza Mivael Olivera,Samouëlian Vanessa,Castonguay Vincent,Arkhipov Alexander,Tekin Cumhur,Li Kan,Martin Nguyen Allison,Monberg Matthew J,Colombo Nicoletta,Lorusso Domenica

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials;Osann;Gynecol Oncol,2014

2. Impact of cervical cancer on quality of life of women in Hubei, China;Thapa;Sci Rep,2018

3. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial;Nunes de Arruda;Int J Gynecol Cancer,2020

4. Quality of life of patients with advanced cervical cancer before and after chemoradiotherapy;Dahiya;Asian Pac J Cancer Prev,2016

5. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer;Eleje;Cochrane Database Syst Rev,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer;Taiwanese Journal of Obstetrics and Gynecology;2024-09

2. Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer;Journal of Obstetrics and Gynaecology;2024-08-16

3. Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials;PLOS ONE;2024-08-12

4. Comparison of two platinum-containing chemotherapy regimens in the treatment of advanced cervical cancer with concurrent chemoradiotherapy;Annals of Medicine;2024-08-02

5. The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Cervical Cancer (v2024.0);Journal of Clinical Medicine;2024-07-25